Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Oct 15;100(8):2079–2084. doi: 10.1172/JCI119741

A synthetic peptide derived from the sequence of a type I collagen receptor inhibits type I collagen-mediated platelet aggregation.

T M Chiang 1, A H Kang 1
PMCID: PMC508399  PMID: 9329973

Abstract

A synthetic peptide-1, an 18 amino acid residue peptide derived from a hydrophilic domain of a cloned platelet type I collagen receptor, was used to study the role of the receptor on types I and III collagen-induced platelet aggregation and the release of ATP. The peptide inhibits the type I, but not the type III, collagen-induced platelet aggregation and the release of ATP in a dose-dependent manner. The [125I]peptide-1 specifically binds to type I collagen-coated microtiter wells in a dose-dependent manner (with Kd = 10 nM). The binding of [125I]peptide-1 can be inhibited by an excess of unlabeled peptide-1 suggesting that the binding is specific. The labeled peptide-1 does not bind to type III collagen-coated microtiter wells. Results from an enzyme-linked immunosorbent assay show that the peptide reacts with the poly- and monoclonal antibodies raised against the purified platelet type I collagen receptor (Mr 65 kD). The peptide also inhibits the adhesion of platelets on type I collagen matrix and rabbit aortic segments in a dose-dependent manner. These results suggest that the reactive site of the platelet receptor for type I collagen resides in this portion of the molecule.

Full Text

The Full Text of this article is available as a PDF (182.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BORN G. V. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962 Jun 9;194:927–929. doi: 10.1038/194927b0. [DOI] [PubMed] [Google Scholar]
  2. Barber A. J., Jamieson G. A. Isolation and characterization of plasma membranes from human blood platelets. J Biol Chem. 1970 Dec 10;245(23):6357–6365. [PubMed] [Google Scholar]
  3. Chiang T. M., Beachey E. H., Kang A. H. Interaction of a chick skin collagen fragment (alpha1-CB5) with human platelets. Biochemical studies during the aggregation and release reaction. J Biol Chem. 1975 Sep 10;250(17):6916–6922. [PubMed] [Google Scholar]
  4. Chiang T. M., Jin A., Kang A. H. Platelet-collagen interaction. Inhibition by a monoclonal antibody raised against collagen receptor. J Immunol. 1987 Aug 1;139(3):887–892. [PubMed] [Google Scholar]
  5. Chiang T. M., Kang A. H., Dale J. B., Beachey E. H. Immunochemical studies of the purified human platelet receptor for the alpha 1(I)-chain of chick skin collagen. J Immunol. 1984 Aug;133(2):872–876. [PubMed] [Google Scholar]
  6. Chiang T. M., Kang A. H. Isolation and purification of collagen alpha 1(I) receptor from human platelet membrane. J Biol Chem. 1982 Jul 10;257(13):7581–7586. [PubMed] [Google Scholar]
  7. Chiang T. M., Rinaldy A., Kang A. H. Cloning, characterization, and functional studies of a nonintegrin platelet receptor for type I collagen. J Clin Invest. 1997 Aug 1;100(3):514–521. doi: 10.1172/JCI119560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chiang T. M., Seyer J. M., Kang A. H. Collagen-platelet interaction: separate receptor sites for types I and III collagen. Thromb Res. 1993 Sep 15;71(6):443–456. doi: 10.1016/0049-3848(93)90118-8. [DOI] [PubMed] [Google Scholar]
  9. Davis G. E. Affinity of integrins for damaged extracellular matrix: alpha v beta 3 binds to denatured collagen type I through RGD sites. Biochem Biophys Res Commun. 1992 Feb 14;182(3):1025–1031. doi: 10.1016/0006-291x(92)91834-d. [DOI] [PubMed] [Google Scholar]
  10. Deckmyn H., Van Houtte E., Vermylen J. Disturbed platelet aggregation to collagen associated with an antibody against an 85- to 90-Kd platelet glycoprotein in a patient with prolonged bleeding time. Blood. 1992 Mar 15;79(6):1466–1471. [PubMed] [Google Scholar]
  11. Gartner T. K., Bennett J. S. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. J Biol Chem. 1985 Oct 5;260(22):11891–11894. [PubMed] [Google Scholar]
  12. Kotite N. J., Staros J. V., Cunningham L. W. Interaction of specific platelet membrane proteins with collagen: evidence from chemical cross-linking. Biochemistry. 1984 Jun 19;23(13):3099–3104. doi: 10.1021/bi00308a038. [DOI] [PubMed] [Google Scholar]
  13. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  14. Moroi M., Jung S. M., Okuma M., Shinmyozu K. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest. 1989 Nov;84(5):1440–1445. doi: 10.1172/JCI114318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ruoslahti E., Pierschbacher M. D. New perspectives in cell adhesion: RGD and integrins. Science. 1987 Oct 23;238(4826):491–497. doi: 10.1126/science.2821619. [DOI] [PubMed] [Google Scholar]
  16. Santoro S. A., Zutter M. M., Wu J. E., Staatz W. D., Saelman E. U., Keely P. J. Analysis of collagen receptors. Methods Enzymol. 1994;245:147–183. doi: 10.1016/0076-6879(94)45010-2. [DOI] [PubMed] [Google Scholar]
  17. Seyer J. M., Kang A. H. Covalent structure of collagen: amino acid sequence of alpha 1(III)-CB9 from type III collagen of human liver. Biochemistry. 1981 Apr 28;20(9):2621–2627. doi: 10.1021/bi00512a040. [DOI] [PubMed] [Google Scholar]
  18. Seyer J. M., Mainardi C., Kang A. H. Covalent structure of collagen: amino acid sequence of alpha 1 (III)-CB5 from type III collagen of human liver. Biochemistry. 1980 Apr 15;19(8):1583–1589. doi: 10.1021/bi00549a008. [DOI] [PubMed] [Google Scholar]
  19. Staatz W. D., Fok K. F., Zutter M. M., Adams S. P., Rodriguez B. A., Santoro S. A. Identification of a tetrapeptide recognition sequence for the alpha 2 beta 1 integrin in collagen. J Biol Chem. 1991 Apr 25;266(12):7363–7367. [PubMed] [Google Scholar]
  20. Staatz W. D., Walsh J. J., Pexton T., Santoro S. A. The alpha 2 beta 1 integrin cell surface collagen receptor binds to the alpha 1 (I)-CB3 peptide of collagen. J Biol Chem. 1990 Mar 25;265(9):4778–4781. [PubMed] [Google Scholar]
  21. Tandon N. N., Kralisz U., Jamieson G. A. Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem. 1989 May 5;264(13):7576–7583. [PubMed] [Google Scholar]
  22. Yamada K. M. Adhesive recognition sequences. J Biol Chem. 1991 Jul 15;266(20):12809–12812. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES